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Abstract 
Objectives: Chronic obstructive pulmonary disease (COPD) is a widespread disease. It produces some night 
symptoms such as nighttime cough and dyspnea. Then subjective and objective changes in sleep pattern are 
expected. Present study was conducted to determine frequency of sleepiness and quality of sleep in patients with 
COPD. Materials & methods: Present case-control study has been performed on 120 patients with diagnosis of 
COPD who had been referred to pulmonary disease clinic in a University teaching hospital. One hundred twenty 
age- and sex- matched healthy individuals were recruited in the study and served as control. Spirometry (PFT) 
was performed for all patients. Patients were categorized under 3 groups in relation to their PFT as follow: mild 
COPD (FEV1/FVC<70% and FEV1≥80%), moderate COPD (FEV1/FVC<70% and 50%≤FEV1<80%), and 
severe COPD (FEV1/FVC<70% and FEV1<50%). Pittsburgh Sleep Quality questionnaire (PSQI) and Epworth 
Sleepiness Scale (ESS) were used to estimate quality of sleep and daytime sleepiness in the patients and control 
group. The collected data were analyzed using version 16 SPSS software. Student's T- test, Chi- square and 
multiple logistic regressions were used as appropriated. Results: 120 patients with COPD (79 males and 41 
females) and 120 normal individuals responded to the questionnaires. Mean scores of quality of sleep were 
8.03±3.66 and 4.2±2.8 in COPD patients and control group respectively. 32.1% of the patients had good sleep 
quality (PSQI score less than 5) and 67.9% had poor sleep quality. Daytime sleepiness (ESS≥ 10) was present in 
34.8% of the patients and 15% of control people. Multiple logistic regressions showed that the patients reported 
significantly worse sleep quality and more daytime sleepiness than control group [OR=2.9; 95% CI (1.6-3.7) & 
OR=3.5; 95% CI (2.5-4.3) respectively]. Conclusion: Results of present study confirmed that COPD is 
associated with daytime sleepiness and poor quality of sleep, possibly attributable to nighttime respiratory 
difficulties and concomitant sleep apnea. Assessment of the patients for symptoms of sleep apnea, daytime 
sleepiness should be a part of regular follow up visits of patients with COPD. 
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1. Introduction 
Chronic obstructive pulmonary disease (COPD) is a widespread disease particularly with increase in age. It is 
estimated that 8-10 percent of adult population suffers from COPD (Owens et al., 2010; Løkke et al., 2006; 
Brutsche et al., 2006; Sanders et al., 2003). COPD exerts some impacts on quality of life of the patients as an 
unrelieved incapacitating disease (Vlipour et al., 2011).  
The disease produces some night symptoms such as nighttime cough and dyspnea. Then subjective and objective 
changes in sleep pattern are expected. Nocturnal blood oxygen saturation decreases as a result of COPD, to end 
with pulmonary hypertension, cardiac arrhythmia, and patient's arousal (Pauwels et al., 2001; Fleatham, 2003).  
There are few studies about sleep disorders in COPD patients (Chaouat et al., 1995; Klink et al., 1987 & 1994). 
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They have implied that patients' symptoms may influence quality of sleep in patients with COPD (Chervin et al., 
2000; Scharf et al., 2010). Study on patients with COPD has demonstrated that 70% of the patients have had 
poor quality of sleep (PSQI>5) (Nunes et al., 2009). In another study conducted to evaluate quality of sleep in 
100 patients with COPD compared to control group, patients with COPD had shorter sleep duration, more delay 
in start of sleep, more frequent night awakening and lower nighttime oxygen saturation (Lofdahl et al., 2008).  
There is no study about the matter among Iranian population. Present study was conducted to determine 
frequency of sleepiness and quality of sleep in patients with COPD and compare them with control. 
2. Methods 
Present case-control study has been performed on patients with diagnosis of COPD who referred consecutively 
to pulmonary disease clinic in a University teaching hospital, Qazvin city, in central part of Iran during Mar 2012 
to Apr 2012. In this study, inclusion criteria in patients group were: 1) age more than 40 years; 2) 
Pulmonologist-diagnosed COPD according to history of smoking, airflow obstruction on spirometry, and the 
presence of at least one symptom related to COPD; 3) no hospitalization and no exacerbation within one month 
prior to the study. Exclusion criteria in both patients and control groups were: 1) history of other major 
pulmonary diseases; or 2) history of another chronic disease. 
The patients were initially evaluated by a pulmonologist for assessment of severity of their disease. Their 
pulmonary function test (PFT) was assessed according to American thoracic medicine society. They were 
categorized under 3 groups in relation to their PFT results as follow: mild COPD (FEV1/FVC<70% and 
FEV1≥80%), moderate COPD (FEV1/FVC<70% and 50%≤FEV1<80%), and severe COPD (FEV1/FVC<70% 
and FEV1<50%). The patients provided informed consent for participation into the study.  
120 patients were included in the study. Another 120 individuals with comparable age and gender were also 
selected and served as control. Demographic data of the patients include their age, gender, level of education, 
history of cigarette smoking, and night snoring were inquired and recorded. 
Pittsburgh Sleep Quality questionnaire (PSQI) was used to estimate quality of sleep in the patients. The 
questionnaire has 89.6% sensitivity and 86.5% specificity. Patient's opinion about his/her sleep quality during 
last 4 weeks was asked in this questionnaire. Finally 0-3 score was given in 7 sections according to Likert 
scoring; so total score of the patients would be 0-21. Score more than 5 means poor sleep quality (Buysse et al., 
1989).  
Epworth Sleepiness Score (ESS) was employed to evaluate daytime sleepiness in the participants. The 
questionnaire comprises 8 questions which define situations that in them the patient may face with sleepiness 
inadvertently. Each question takes 0-3 score. If total score of the patients is more than 10, he/she experience 
more than standard daytime sleepiness (Dohns, 1999).   
The collected data were analyzed using SPSS software version 16. Quantitative parameters were reported as 
mean± SD. Qualitative parameters were reported as number and percent. T-test, chi-square test and multiple 
logistic regressions were used to evaluate relationship between parameters. 
3. Results 
120 patients with COPD (79 males and 41 females) and 120 normal individuals responded to the questionnaires. 
Mean age of the patients was 66.4±10.8 years. Their mean BMI was 25.91±4.97.  
Demographic characteristics of the patients group and control group have been demonstrated in Table 1. 
Summary of notable demographic variables of the patients and results of analysis of the filled questionnaires 
sorted by severity of their disease have been displayed in Table 2.  
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Table 1. Demographic characteristics of the patients group and control group 
P-value Control group (n=120) Patients with COPD (n=120) Variables 
0.21 6.4±57.3 10.8±66.4 age 
 
0.09 
  Sex:  
65 (54.1%) 79 (65.8%) male 
55 (45.8%) 41 (34.2%) Female 
0.2 
  Marital status:  
18 (15%) 29 (24.2%) single 
102 (85%) 91 (75.8%) married 
0.07 4.1±9.2 3.7±7.6 Level of education (years) 
0.08 3.2  ± 27.1 4.9   ± 25.9 BMI 
0.06 
  Cigarette smoking:  
37 (30.8%) 61 (50.8%) yes 
83 (69.2%) 59 (49.2%) no 
0.01 18 (15%) 38 (31.6%) Daytime sleepiness 
0.002 23 (19.1%) 58 (48.3%) Night snoring 
 
Table 2. Notable demographic variables of the patients and results of analysis of the filled questionnaires sorted 
by severity of their disease 
P-value Severe COPD (n=42) 
Moderate COPD 
(n=58) 
Mild COPD 
(n=20) Variables 
0.07 10.3±69.4 6.9±62.7 57.8±12.1 age 
0.12 
   Sex: 
30 (25%) 41 (34.1%) 8 (6.6%) male 
12 (10%) 17 (14.1%) 12 (10%) Female 
0.08 5.8±25.2 4.1±26.1 3.7±25.8 BMI 
0.02 0.4±0.91 0.9±1.42 0.5±1.76 FEV1 
0.04 4.1±12.1 4.7±9.1 3.2±9.9 Daytime sleepiness 
0.07 
   Night snoring:  
15 (12.5%) 25 (20.8%) 18 (15%) yes 
27 (22.5%) 33 (27.5%) 2 (1.6%) no 
0.03 
0.06 
0.1 
0.08 
0.04 
0.02 
0.05 
0.09 
3.4±9.1 
0.6±1.7 
0.6±0.9 
0.8±1.3 
0.9±1.5 
1.1±2.1 
0.7±2.2 
0.9±1.9 
6.1±8.3 
0.4±1.6 
0.5±1.1 
0.7±0.9 
0.5±1.4 
0.3±1.4 
0.4±1.7 
0.5±1.7 
5.3±7.8 
0.6±1.3 
0.7±1.0 
0.6±1.1 
0.8±1.2 
0.5±1.7 
0.7±1.8 
0.9±1.8 
Sleep quality 
Subjective sleep quality 
Delay in initiation of sleep 
Sleep duration 
Sleep satisfaction 
Sleep disturbance 
Use of hypnotic drugs 
Disturbance in daytime activities 
 
67.9% of the patients had poor sleep quality as said by their Pittsburgh questionnaire, whereas only 27.5% in 
control group had poor sleep quality. Mean scores of quality of sleep were 8.03±3.66 and 4.2±2.8 in COPD 
patients and control group respectively. Detailed results of analysis of Pittsburgh questionnaire have been shown 
in Table 3. Results from multiple logistic regressions showed that patients have reported significantly worse 
sleep quality than control group [OR=2.9; 95% CI (1.6-3.7)].  
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Table 3. Results of analysis of Pittsburgh questionnaire in studied patients 
P-value OR (95%CI) Control group  Patients group   
0.02 2.9 (1.6-3.7) 4.2±2.8 8.03±3.66 Total score of PSQI 
0.03  1.9 (1.1-2.6) 0.7±1.4  0.8±1.9  Subjective sleep quality 
0.04  2.1 (1.3-2.9) 0.7±0.9  0.5±1.3  Delay in initiation of sleep 
0.2  1.5 (0.6-2.1) 0.8±1.3  0.6±1.5  Sleep duration 
0.009  3.1 (1.9-4.2) 0.4±0.9  0.9±1.4  Sleep satisfaction 
0.07  1.6 (0.8-1.9) 0.6±1.9  1.1±2.1  Sleep disturbance 
0.007  2.6 (1.5-3.7) 0.5±1.2  0.7±2.2  Use of hypnotic drugs 
0.005  2.5 (1.3-3.6) 0.3±1.1  0.9±1.9  Disturbance in daytime activities 
 
Mean total ESS score was 9.9±3.4 and 6.8±2.6 in COPD patients and control group, respectively. Also daytime 
sleepiness was significantly higher in COPD patients compared to control people [OR=3.5; 95% CI (2.5-4.3)].  
4. Discussion 
Previous studies showed that the quantity and quality of sleep influences quality of life in chronic diseases such 
as COPD (Hynninen et al., 2007; Cully et al., 2006). It has been claimed that sleep disorders is the third 
determinant of quality of life in patients with COPD, after dyspnea and tiredness (Cavalcante et al., 2012). 
Consequently, presence of sleep disorders and evaluation of sleep quality should be noticed in patients with 
COPD. 
Present study evaluated quality of sleep in patients with COPD using Pittsburgh questionnaire (PSQI). Mean 
scores of quality of sleep were 8.03±3.66 and 4.2±2.8 in COPD patients and control group respectively. 32.1% of 
the patients had good sleep quality (PSQI score less than 5) and 67.9% had poor sleep quality. The corresponding 
figures were 72.5% and 27.5% for control group respectively. PSQI score has been 11±5.4 in a group of COPD 
evaluated by Scharf; which denotes poor sleep quality in them (Scharf et al., 2010). Another study has confirmed 
that COPD patients had more delay in start of sleep, more frequent night awakening and lower nighttime blood 
oxygen saturation, compared to control group (Lofdahl et al., 2008). Present study again corroborated that poor 
sleep quality is quite prevalent in COPD patients.  
COPD patients with more severe disease had poorer sleep quality in current study, since lower FEV1 went along 
with higher PSQI score. It is consistent with a study that has illustrated more severe diurnal hypoxemia is 
correlated with lower sleep effectiveness score in polysomnography (McSharry et al., 2012). 
Decline in sleep quality is also seen in other conditions that are concomitant with nighttime hypoxemia such as 
asthma and emphysema. Sleep is adjusted by various neurotransmitters such as nor-adrenaline, melatonin, acetyl 
choline, serotonin, histamine, and dopamine. Hypoxemia may affect sleep characteristics through changes in the 
level of these neurotransmitters. Several animal and human studies have suggested that nighttime oxygen therapy 
recovers sleep quality in the patients (Glodstein et al., 1984; Ray et al., 2011).  
COPD patients had lower PSQI score and sub-scores in present study; compared to control. Their sleepiness was 
higher too. Similar studies have reached to the same conclusion too. Studies conducted on patients with COPD 
and chronic bronchitis have reported more frequent night snoring and daytime sleepiness in the patients matched 
up to control (Koutsourelakis et al., 2008; Karachaliou et al., 2007). Sleep fractioning, concomitant sleep apnea 
and prescribed drugs may aggravate the problem (Nunes et al., 2009; Lofdahl et al., 2008; Buysse et al., 1989). 
Prevalence of COPD has been higher in patients with diagnosis of sleep apnea in a sleep clinic. Association 
between two diseases has estimated 11-16% (Chaouat et al., 1995; Resta et al., 2002). The term "Overlap 
Syndrome" was used to describe the combination of chronic obstructive pulmonary disease and obstructive sleep 
apnea syndrome (Weitzenblum et al., 2008).  
Limitations of this study need to be mentioned. It seems more convenient that polysomnography would be used 
for evaluation of sleep in the patients, however technical limitations preclude this. Also determination of disease 
severity was performed by PFT. Assessment of arterial CO2 concentration seems more appropriate. Again it is an 
invasive procedure and was discarded.  
 
 
5. Conclusion 
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In summary, results of present study confirmed that COPD is associated with poor quality of sleep, possibly 
attributable to nighttime respiratory difficulties and concomitant sleep apnea. Assessment of the patients for 
symptoms of sleep apnea, daytime sleepiness and other sleep disorders should be taken into account during 
regular follow up visits of patients with COPD. 
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